These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22024288)

  • 1. Serum visfatin and vaspin levels in normoglycemic first-degree relatives of Iranian patients with type 2 diabetes mellitus.
    Akbarzadeh S; Nabipour I; Jafari SM; Movahed A; Motamed N; Assadi M; Hajian N
    Diabetes Res Clin Pract; 2012 Jan; 95(1):132-8. PubMed ID: 22024288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Association between both resistin, visfatin and insulin resistance as well as β cell function in the first-degree relatives of type 2 diabetes mellitus].
    Zhang XJ; Wang Z; Li HH; Yu L; Gao S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Dec; 31(12):1393-6. PubMed ID: 21223671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels.
    Akbarzadeh S; Nabipour I; Assadi M; Movahed A; Jafari SM; Motamed N; Nazem H; Haraghy M; Pourbehi A; Bargahi A; Hajian N
    Cytokine; 2012 May; 58(2):295-9. PubMed ID: 22398372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
    Alghasham AA; Barakat YA
    Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism.
    Martos-Moreno GÁ; Kratzsch J; Körner A; Barrios V; Hawkins F; Kiess W; Argente J
    Int J Obes (Lond); 2011 Oct; 35(10):1355-62. PubMed ID: 21266955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apelin, vaspin, visfatin and adiponectin in large for gestational age infants with insulin resistance.
    Cekmez F; Canpolat FE; Pirgon O; Çetinkaya M; Aydinoz S; Suleymanoglu S; Ipcioglu OM; Sarici SU
    Cytokine; 2011 Nov; 56(2):387-91. PubMed ID: 21742512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.
    Ozkaya M; Cakal E; Ustun Y; Engin-Ustun Y
    Fertil Steril; 2010 Feb; 93(3):880-4. PubMed ID: 19111298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes.
    Kadoglou NP; Kapelouzou A; Tsanikidis H; Vitta I; Liapis CD; Sailer N
    Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):63-8. PubMed ID: 21031343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
    Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
    Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating visfatin level is correlated with inflammation, but not with insulin resistance.
    Oki K; Yamane K; Kamei N; Nojima H; Kohno N
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):796-800. PubMed ID: 17634078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The comparison of serum vaspin and visfatin concentrations in obese and normal weight women.
    Saboori S; Hosseinzadeh-Attar MJ; Yousefi Rad E; Hosseini M; Mirzaei K; Ahmadivand Z
    Diabetes Metab Syndr; 2015; 9(4):320-3. PubMed ID: 25470626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of novel adipocytokines in patients with colorectal cancer.
    Fazeli MS; Dashti H; Akbarzadeh S; Assadi M; Aminian A; Keramati MR; Nabipour I
    Cytokine; 2013 Apr; 62(1):81-5. PubMed ID: 23474107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk.
    Kadoglou NP; Vrabas IS; Kapelouzou A; Lampropoulos S; Sailer N; Kostakis A; Liapis CD
    Regul Pept; 2011 Oct; 170(1-3):57-61. PubMed ID: 21640762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active visfatin is elevated in serum of maintenance haemodialysis patients and correlates inversely with circulating HDL cholesterol.
    Nüsken KD; Petrasch M; Rauh M; Stöhr W; Nüsken E; Schneider H; Dötsch J
    Nephrol Dial Transplant; 2009 Sep; 24(9):2832-8. PubMed ID: 19389865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance.
    Dogru T; Sonmez A; Tasci I; Bozoglu E; Yilmaz MI; Genc H; Erdem G; Gok M; Bingol N; Kilic S; Ozgurtas T; Bingol S
    Diabetes Res Clin Pract; 2007 Apr; 76(1):24-9. PubMed ID: 16956691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of circulating visfatin concentrations with insulin resistance and low-grade inflammation after dietary energy restriction in Spanish obese non-diabetic women: role of body composition changes.
    Agueda M; Lasa A; Simon E; Ares R; Larrarte E; Labayen I
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):208-14. PubMed ID: 20951014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.
    Caixàs A; Tirado R; Vendrell J; Gallart L; Megía A; Simón I; Llauradó G; González-Clemente JM; Giménez-Palop O
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):733-8. PubMed ID: 19222486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC).
    Pazgan-Simon M; Kukla M; Zuwała-Jagiełło J; Derra A; Bator M; Menżyk T; Lekstan A; Grzebyk E; Simon K
    PLoS One; 2020; 15(1):e0227459. PubMed ID: 31935230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.